Related Experiment Video
Updated: Feb 27, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Things that could be Mycoplasma pneumoniae
Ruben C A de Groot1, Patrick M Meyer Sauteur2, Wendy W J Unger1
1Laboratory of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center, Rotterdam, The Netherlands.
Abstract:
M. pneumoniae infection gives rise to a wide variety of manifestations. The pathogenesis of secondary manifestations is not always known. Some depend on the direct invasion of M. pneumoniae and others on the indirect effect of M. pneumoniae through pathological immune responses, for instance autoreactive antibodies in Guillain-Barré Syndrome. Diagnosis remains challenging with currently available diagnostic tests, because they do not demonstrate a causal relation due to M. pneumoniae asymptomatic carriage or previous infection. The mainstay of treatment is macrolide antibiotics, but the role of additional immunomodulation therapy is unclear. Knowledge of the pathogenesis of the different manifestations should guide strategies for diagnosis and treatment.
Insights
Mycoplasma pneumoniae infections cause diverse symptoms, some due to direct invasion and others to immune responses. Understanding pathogenesis is key for better diagnosis and treatment strategies.
Area of Science:
- Infectious Diseases
- Immunology
- Neurology
Background:
- Mycoplasma pneumoniae infections present with varied clinical manifestations.
- The exact mechanisms behind secondary manifestations are not fully understood.
- Some manifestations result from direct bacterial invasion, while others stem from immune system dysregulation, such as autoreactive antibodies seen in Guillain-Barré Syndrome.
Purpose of the Study:
- To explore the pathogenesis of Mycoplasma pneumoniae-associated manifestations.
- To highlight diagnostic challenges and potential treatment strategies.
Main Methods:
- Review of existing literature on Mycoplasma pneumoniae pathogenesis and clinical presentations.
- Analysis of mechanisms linking infection to secondary conditions.
Main Results:
- Pathogenesis involves both direct M. pneumoniae invasion and indirect immune-mediated effects.
- Diagnostic tests face limitations in establishing causality due to asymptomatic carriage or prior infections.
- The efficacy of immunomodulation therapy alongside macrolides requires further investigation.
Conclusions:
- Understanding the diverse pathogenic pathways of M. pneumoniae is crucial.
- Improved diagnostic approaches are needed to confirm causal links.
- Tailoring treatment strategies based on a deeper knowledge of pathogenesis may enhance patient outcomes.
Related Concept Videos
Bacterial Phylum Tenericutes
Pneumonia III: Complications and Assessment
Methods of Classification and Identification
Bacterial Phylum Actinobacteria
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbial Morphologies

